CNBC Power Lunch This biotech company is trying to stop or reverse age-related diseases (September 13, 2018)
CNBC.com Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging (Aug 29, 2018)
Our mission is to extend human healthspan, the period in one’s life unburdened by the disease of aging.
Working at the frontier of biotechnology and medicine, UNITY’s goal is to halt, slow or reverse age-associated diseases, while restoring human health.
Management
Members of UNITY’s management team have collectively advanced nearly 100 therapeutic candidates into human clinical trials and are responsible for 13 FDA-approved medicines.
KEITH R. LEONARD JR.
Chairman and CEO
NATHANIEL DAVID, Ph.D.
Co-Founder and President
DAN MARQUESS, D. Phil
Chief Scientific Officer
JAMIE DANANBERG, M.D.
Chief Medical Officer
BOB GOELTZ
Chief Financial Officer
TAMARA L. TOMPKINS
General Counsel
SUSAN LUNDEEN
Senior Vice President of People
PEDRO J. BELTRAN, Ph.D.
Senior Vice President of Biology
DOUGLAS RICH
Senior Vice President of Operations
CAMILLE LANDIS
Senior Vice President of Corporate Development
BOARD OF DIRECTORS
PAUL L. BERNS
Former President and Chief Executive Officer,
Anacor Pharmaceuticals, Inc.
KRISTINA BUROW
Managing Director,
ARCH Venture Partners
GRAHAM COOPER
Chief Financial Officer and Chief Operating Officer,
Assembly Biosciences, Inc.
NATHANIEL DAVID, PH.D.
Co-Founder and President,
UNITY Biotechnology
DAVID LACEY, M.D.
Former Senior Vice President of Research,
Amgen
KEITH R. LEONARD JR.
Chairman and CEO,
UNITY Biotechnology
ROBERT T. NELSEN
Co-Founder and Managing Director,
ARCH Venture Partners
CAMILLE SAMUELS
Partner,
Venrock
FOUNDERS
NATHANIEL DAVID, Ph.D.
President
JAN VAN DEURSEN, Ph.D.
Professor of Biochemistry and Molecular Biology at The Mayo Clinic; Professor of Pediatrics at The Mayo Clinic
JUDITH “JUDY” CAMPISI, Ph.D.
Professor at the Buck Institute for Research on Aging; Senior Scientist at Lawrence Berkeley National Laboratory
DAOHONG ZHOU, M.D.
Professor of Pharmacodynamics and Radiation Oncology, University of Florida at Gainesville
Nature Reviews Drug Discovery Anti-ageing pipleine starts to mature (August 3, 2018)
